People: Cara Therapeutics Inc (CARA.OQ)
24 May 2019
Dr. Mani Mohindru, Ph.D., serves as Chief Financial Officer, Chief Strategy Officer of the Company. effective from August 15, 2017. Dr. Mohindru brings more than a decade of leadership experience in the biopharmaceutical industry to Cara. Most recently, she served as Chief Strategy Officer at Curis, Inc. (Nasdaq:CRIS), where she was instrumental in the development and management of overall corporate strategy. She was also responsible for the company's engagement with the investment community, building extensive relationships with industry analysts and investors. Earlier in her career, Dr. Mohindru spent several years as an equity research analyst covering the biotechnology sector at ThinkEquity, LLC, Credit Suisse and UBS. She also co-founded Immtox LLC, a privately held biotechnology company, and was a healthcare industry consultant at Axon Healthcare Partners and SAI Healthcare (acquired by IMS Health). Dr. Mohindru received her Ph.D. in neurosciences from Northwestern University.
|Total Annual Compensation, USD||184,091|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||3,862,380|
|Fiscal Year Total, USD||4,046,470|